Statistics

Total Visits

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial49

Select a period of time:

Number of views in the range

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial24

Views

Views
May 20252
June 20250
July 202511
August 20251
September 20257
October 20252
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil9
Venezuela2
United Kingdom2
Turkey1
 

Top cities views

Views
Dallas6
Abilene1
Barão de Cocais1
Bento Fernandes1
Caracas1
Ciudad Ojeda1
Confins1
Curitiba1
El Paso1
Guarulhos1